Akebia Asks Court to Bar Astra From Patent Suits on Anemia Drug
Bloomberg Law News. Bloomberg Law Analysis · Podcasts · Submit a News Tip. Go. Subscription Information. Login to see your account. Login.
PATENT NEWS
-
In: PATENT NEWS
-
In: PATENT NEWS
Texas Jury Hands Apple $308.5M Verdict in Patent Trial – Haute Lawyer – Haute Living
Texas Jury Hands Apple $308.5M Verdict in Patent Trial – Haute Lawyer Haute Living
-
In: PATENT NEWS
Apple won 77 patents today covering the Apple Watch Digital Crown used for ECG, Adjustable Optical Layers for future Eyewear & more – Patently Apple
Apple won 77 patents today covering the Apple Watch Digital Crown used for ECG, Adjustable Optical Layers for future Eyewear & more Patently Apple
-
In: PATENT NEWS
Greenberg Traurig Continues Life Sciences, IP Growth With 5-Attorney Hire From Wilson Sonsini
Five intellectual property and life sciences attorneys and a patent agent have joined Greenberg Traurig from the Am Law 100 firm Wilson Sonsini …
-
In: PATENT NEWS
Copyright bots powered by a 1998 law threaten the public’s right to know
A post from NYU’s Journal of Intellectual Property and Entertainment Law has called copyright actions like YouTube’s “a tool for censorship, bullying, …
-
In: PATENT NEWS
Walter Reed scientist granted patent for A. baumannii antibody – TechLink – TechLink
Walter Reed scientist granted patent for A. baumannii antibody – TechLink TechLink
-
In: PATENT NEWS
Nike Sues Rap Star ‘Lil Nas X’ And ‘MSCHF’ Over Patent Infringement – pymnts.com
Nike Sues Rap Star ‘Lil Nas X’ And ‘MSCHF’ Over Patent Infringement pymnts.com
-
In: PATENT NEWS
With Issuing of 21st Patent, Innovation Is in the Details at GrowPath – PRNewswire
With Issuing of 21st Patent, Innovation Is in the Details at GrowPath PRNewswire
-
In: PATENT NEWS
Black Judge Chosen for Only Appeals Court Never to Have One (3) – Bloomberg Law
Black Judge Chosen for Only Appeals Court Never to Have One (3) Bloomberg Law
-
In: PATENT NEWS
It’s time to consider a patent reprieve for COVID vaccines – Nature.com
It’s time to consider a patent reprieve for COVID vaccines Nature.com